Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$537,251
+$112,276 QoQ
Shares Held
2,135
+9.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#3,096
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Warwick Investment Management, Inc. holds $3,727,635 across 5 Drug Manufacturers - General names. ABBV ranks #4 (14.4% of the industry book) .
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537,251 | 2,135 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $424,975 | 1,954 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $557,058 | 2,438 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $556,390 | 2,403 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $386,460 | 2,082 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $485,876 | 2,319 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $341,894 | 1,924 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $369,682 | 1,872 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $314,910 | 1,836 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $330,329 | 1,814 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||